Tag: argenx

argenx to Present New Data from Generalized Myasthenia Gravis Program at 2022 American Academy of Neurology Annual Meeting

by admin

April 3, 2022

BREDA, the Netherlands--(BUSINESS WIRE)-- Regulatory Information: argenx SE (Euronext & Nasdaq: ARGX), a world immunology firm dedicated to enhancing the ...

HCMC Proudly Announces Acquisition of EIR Hydration, an IV Therapy Center | Your Money

Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ … | Your Money

by admin

December 18, 2021

VYVGART is the primary and solely FDA-approved neonatal Fc receptor blocker68% ofanti-acetylcholine receptor (AChR) antibody positivegMG sufferers handled with VYVGART ...